drugset / Trial / NCT02202707
Vasomotor Symptoms and Cardiovascular Control
Withdrawn
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital · collabSpaulding Rehabilitation Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to preliminarily determine whether the frequency and/or severity of vasomotor symptoms (VMS) at baseline, and then after symptom reduction with gabapentin, relates to various cardiovascular control measures.
Timeline
- Start
- 2014-05
- Primary completion
- 2016-06
- Completion
- 2016-06
Outcome
Outcome not reported
Stopped (Business): “No funding obtained to conduct study”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Unknown | — | — |
Indications
No indication recorded.